Healthcare and Life Sciences

Contact Us

Duff & Phelps Healthcare and Life Sciences team provides Fortune 500 corporations, middle-market and growth companies and financial sponsors access to our valuation and corporate finance services.

Our dedicated team completes nearly 200 healthcare engagements annually, including engagements in healthcare services, Pharmaceuticals, Medical Technology and Life Sciences. As a firm, Duff & Phelps stands alone in our objectivity, deep technical and industry expertise and breadth of advisory services.

/industries/healthcare-and-life-sciences /-/media/feature/industries/desktop/health-life-sciences.jpg industry {D59CA77E-C551-45A3-BE89-F567210C5A60} {DC6234F2-03B5-4F3D-9CDE-146A80B170AD} {6B6F3B01-98A6-4BC2-B2CD-CBD127447FB5} {5CE144D0-ADDC-43A3-95E4-3428CA819BF8} {D3AE3EC6-3254-4441-B111-1AF8D558906C} {13E28841-C245-441D-8C3B-49E72DA5381C} {C8894F56-FF6C-4DEA-AB91-58D66A7F0624} {B062D54C-1425-4A04-8F9F-95EA14068E6D}

Other Areas We Can Help

Corporate Finance

Comprehensive support throughout mergers and acquisitions and other corporate transactions.

Corporate Finance
Private Capital Markets

Private Capital Markets

Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.

Private Capital Markets
Transaction Advisory Services

Transaction Advisory Services

Seamless analytical advisory through the deal continuum, from transaction origination to closing.

Transaction Advisory Services

Financial Sponsors Group

Dedicated coverage and access to M&A deal-flow for financial sponsors.

Financial Sponsors Group

Valuation Advisory

Valuation and consulting for financial reporting; federal, state and local tax; investment; and risk management purposes.

Valuation Advisory

Case Studies

Insights

M&A Advisory

Healthcare Services Sector Update – June 2021

M&A Advisory
M&A Advisory

Food and Beverage M&A Landscape – Summer 2021

M&A Advisory
M&A Advisory

Staffing Industry M&A Landscape – Summer 2021

M&A Advisory
Valuation

Things are Improving, but …

Valuation

News